David Goodman's lobbying: the registrations they file and every meeting they've reported since November 2021.
← Lobbying
Registrant (responsible officer)
David Goodman
Chief Executive Officer
For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Meetings this Parliament
175
Since Nov 2021
205
Active registrations
1
Dec 2024 Reports per month Nov 2026
Reported meetings
Loic Sénéchal · Conseiller regional pour le Quebec, Public Services and Procurement Canada (PSPC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Cyril Nawar · Conseiller regional pour le Quebec de Carlos Leitao, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Joël Lightbound · Ministre de la Transformation du gouvernement, des Travaux publics et de l’Approvisionnement et lieutenant du Québec, Public Services and Procurement Canada (PSPC)
Chanel Sterie · Conseillère principale, Public Services and Procurement Canada (PSPC)
Loic Sénéchal · Conseiller regional pour le Quebec, Public Services and Procurement Canada (PSPC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Joël Lightbound · Ministre de la Transformation du gouvernement, des Travaux publics et de l’Approvisionnement et lieutenant du Québec, Public Services and Procurement Canada (PSPC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
Paul Moen · Chef de Cabinet, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Marjorie Michel · Ministre de la Santé, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Loris Mirella · Directeur, Global Affairs Canada (GAC)
Gabrielle Dolgoy · Directrice adjointe par interim, Global Affairs Canada (GAC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Sandenga Yeba · Directeur des politiques et chef de cabinet adjoint, Health Canada (HC)
Shahad Khalladi · Conseillère principale en politiques, Health Canada (HC)
Justine Frame · Conseillère en politiques, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Arianne Reza · Deputy Minister, Public Services and Procurement Canada (PSPC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
and 1 more Show fewer
Catherine Dong · Adjointe aux communications, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Guillaume Couillard · Directeur général, Patented Medicine Prices Review Board (PMPRB)
Kevin Pothier · Directeur principal, Politiques et de l'analyse économique, Patented Medicine Prices Review Board (PMPRB)
Improvements to the supports offered by the federal government to support R&D; in particular, generic drug research and development.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Sandenga Yeba · Deputy chief of staff and policy director, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Paul Moen · Chef de Cabinet, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Read more
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Sarah Larcher · Adjointe exécutive du chef de cabinet, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Read more
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Dominic LeBlanc · Ministre responsable du commerce entre le Canada et les États-Unis, Global Affairs Canada (GAC)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
Sara Larcher · Adjointe exécutifve du chef de cabinet, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Read more
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
sara Larcher · Adjoint(e) exécutif(ve) du chef de cabinet, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Read more
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
David McFarlane · Directeur des politiques, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Read more
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
David McFarlane · Directeur des politiques, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Read more
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Read more
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Read more
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
David McFarlane · Directeur des politiques, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Read more
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
Official report
← Newer
Page 5
Older →
From the Office of the Commissioner of Lobbying's open data , published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence .
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.